John Butler
Chief Executive Officer presso AKEBIA THERAPEUTICS, INC.
Patrimonio netto: 4 M $ in data 29/02/2024
Profilo
John P.
Butler occupies the position of President, CEO, Chief Financial Officer & Director at Akebia Therapeutics, Inc.
In the past he was Chief Executive Officer of Inspiration Biopharmaceuticals, Inc., Product Manager at Amgen, Inc., President-Personalized Genetic Health & Senior VP at Genzyme Corp., Head-Sales & Marketing at Hoffmann-La Roche, Inc., Chairman of Kidney Care Partners and Chairman for American Kidney Fund, Inc.
John P.
Butler received an MBA from Baruch College and an undergraduate degree from Manhattan College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
29/02/2024 | 2 364 436 ( 1.26% ) | 4 M $ | 29/02/2024 |
Posizioni attive di John Butler
Società | Posizione | Inizio |
---|---|---|
AKEBIA THERAPEUTICS, INC. | Chief Executive Officer | 16/09/2013 |
Precedenti posizioni note di John Butler
Società | Posizione | Fine |
---|---|---|
ZYNERBA PHARMACEUTICALS, INC. | Director/Board Member | 10/10/2023 |
KERYX BIOPHARMACEUTICALS | Director/Board Member | 01/01/2017 |
RELYPSA INC | Director/Board Member | 01/09/2016 |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Chairman | 01/01/2015 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Chief Executive Officer | - |
Formazione di John Butler
Manhattan College | Undergraduate Degree |
Baruch College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
AMGEN INC. | Health Technology |
ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
Aziende private | 7 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Health Services |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Health Services |